Bank of New York Mellon’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,538,421
Closed -$1.36M 4481
2022
Q4
$1.36M Buy
1,538,421
+223,787
+17% +$297K ﹤0.01% 3045
2022
Q3
$2.06M Buy
1,314,634
+105,495
+9% +$239K ﹤0.01% 2832
2022
Q2
$2.43M Buy
1,209,139
+223,637
+23% +$387K ﹤0.01% 2721
2022
Q1
$2.3M Buy
985,502
+27,241
+3% +$85K ﹤0.01% 2854
2021
Q4
$4.46M Sell
958,261
-204,124
-18% -$1.27M ﹤0.01% 2525
2021
Q3
$8.87M Buy
1,162,385
+149,208
+15% +$1.27M ﹤0.01% 2196
2021
Q2
$9.82M Buy
1,013,177
+104,926
+12% +$836K ﹤0.01% 2145
2021
Q1
$7.51M Sell
908,251
-20,177
-2% -$213K ﹤0.01% 2252
2020
Q4
$6.34M Buy
928,428
+172,990
+23% +$1.39M ﹤0.01% 2244
2020
Q3
$8.42M Buy
755,438
+108,734
+17% +$995K ﹤0.01% 1945
2020
Q2
$4.06M Buy
646,704
+234,607
+57% +$898K ﹤0.01% 2314
2020
Q1
$758K Buy
412,097
+7,633
+2% +$22K ﹤0.01% 3157
2019
Q4
$1.37M Sell
404,464
-28,064
-6% -$66.9K ﹤0.01% 3068
2019
Q3
$926K Sell
432,528
-20,529
-5% -$47.8K ﹤0.01% 3220
2019
Q2
$1.21M Buy
453,057
+16,906
+4% +$60.8K ﹤0.01% 3091
2019
Q1
$2.07M Buy
436,151
+13,700
+3% +$35.9K ﹤0.01% 2757
2018
Q4
$1.01M Buy
422,451
+25,085
+6% +$81.9K ﹤0.01% 3091
2018
Q3
$1.75M Buy
397,366
+84,947
+27% +$471K ﹤0.01% 2927
2018
Q2
$2.25M Buy
312,419
+253,360
+429% +$1.72M ﹤0.01% 2790
2018
Q1
$305K Buy
59,059
+4,461
+8% +$31.7K ﹤0.01% 3792
2017
Q4
$207K Buy
54,598
+21,064
+63% +$54.9K ﹤0.01% 3938
2017
Q3
$57K Buy
33,534
+5,646
+20% +$10.4K ﹤0.01% 4091
2017
Q2
$56K Sell
27,888
-121,536
-81% -$237K ﹤0.01% 4116
2017
Q1
$590K Sell
149,424
-331
-0.2% -$1.66K ﹤0.01% 3488
2016
Q4
$734K Buy
149,755
+38,052
+34% +$229K ﹤0.01% 3427
2016
Q3
$865K Sell
111,703
-6,143
-5% -$41.4K ﹤0.01% 3252
2016
Q2
$660K Sell
117,846
-45
-0% -$288 ﹤0.01% 3399
2016
Q1
$635K Buy
117,891
+28,248
+32% +$164K ﹤0.01% 3320
2015
Q4
$781K Sell
89,643
-3,561
-4% -$30K ﹤0.01% 3317
2015
Q3
$782K Sell
93,204
-77,519
-45% -$1.23M ﹤0.01% 3334
2015
Q2
$3.01M Buy
170,723
+149,084
+689% +$1.92M ﹤0.01% 2656
2015
Q1
$250K Buy
21,639
+6,118
+39% +$70.8K ﹤0.01% 3837
2014
Q4
$156K Buy
15,521
+3,805
+32% +$19.3K ﹤0.01% 3955
2014
Q3
$53K Hold
11,716
﹤0.01% 4140
2014
Q2
$79K Buy
+11,716
New +$88.3K ﹤0.01% 4025

Other funds holding SRNE